BioUtah News
-
bioMérieux receives US FDA 510(k) clearance for the BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini and will apply for CLIA-waiver
Marcy-l’Étoile (France), April 13, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has…
-
PEEL THERAPEUTICS DESCRIBES EXCESSIVE NETOSIS INDUCTION IN LONG COVID
Peer-reviewed study offers first description of ongoing NETosis induction in Long COVID; provides insights into pathogenesis and can…
-
NEW DOMESTIC SUPPLY SOURCE TO HELP ADDRESS CRITICAL SHORTAGE OF MEDICAL RADIOISOTOPES
PROPRIETARY PLATFORM WILL BE CAPABLE OF GENERATING UP TO 12 DIFFERENT RARE ISOTOPES SIMULTANEOUSLY WEST VALLEY CITY, Utah…
-
Bench to Bedside 2023 Competition
Date & Time: April 17th, 2023 | 6:00p – 8:30p Location: Utah State Capitol Building RSVP & Agenda: …
-
BD Introduces Advanced Ultrasound Technology to Help Drive First-Stick Success for IV Insertions
BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control…
-
Nelson Labs® Receives ASCA Accreditation from the U.S. FDA
Nelson Labs, a global leader in microbiological and analytical chemistry testing and advisory services for the medical device…
-
Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting
In a clinical decision effectiveness study, KidneyIntelX classified more Black vs non-Black patients as high risk for progression…
-
ARUP Laboratories Chooses Gestalt’s PathFlow® Solution for Its Strategic Digital Initiatives
SPOKANE, WASHINGTON, and SALT LAKE CITY (April 12, 2023)—Gestalt Diagnostics Inc., a leading provider of artificial intelligence (AI)-powered…
-
Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program
New program will increase access to affordable genetic testing while also helping to identify and elevate high-risk patient…
-
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies
Thermo Fisher Scientific Opens Cell Therapy Facility at UCSF to Accelerate Development of Breakthrough Therapies
-
Intermountain Health Launches Culmination Bio
Intermountain Health announced the launch of Culmination Bio, a biotech company developing an exclusive, anonymized, and de-identified intelligence…
-
Clene announces results of exploratory analysis in treatment of ALS
SALT LAKE CITY, March 09, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”)…
-
Spectrum Solutions Acquires Alimetrix, Inc. and Microarrays, Inc. to Expand Laboratory Products and Testing Capabilities
SALT LAKE CITY–(BUSINESS WIRE)–Spectrum Solutions® today announced the acquisitions of Alimetrix, Inc., a CLIA and CAP accredited molecular…
-
Nomi Health Launches Charitable Foundation to Expand Access to Affordable, High-Quality Healthcare
The Nomi Health Charitable Foundation will broaden the company’s philanthropic investments in healthcare equity, financial and health literacy,…
-
University of Utah, TikkunLev to accelerate heart-failure gene therapy
Salt Lake City – The University of Utah, one of the nation’s leading research universities, and TikkunLev Therapeutics,…
-
Carterra expands best-in-class franchise with the launch of the LSAXT high-throughput SPR biosensor at SLAS 2023
New instrument provides greater sensitivity to enable additional applications for discovery and characterization of novel therapeutics with unrivaled throughput…
-
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry SALT LAKE…
-
BioUtah Recognizes Rare Disease Day 2023
BioUtah President and CEO, Kelvyn Cullimore, commented on Rare Disease Day held on February 28, 2023. “Today is…
-
SDNA Saliva Collection FDA 510(k) Class II Medical Device Clearance
SALT LAKE CITY, UTAH—Spectrum Solutions, LLC today announced the U.S. Food and Drug Administration (FDA) has granted 510(k)…
-
Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT® MD™ Surgical Guidance System
Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment…
-
Still on the Hill…
BioUtah continues to monitor issues of importance to our industry and engage with legislators on Utah’s Capitol Hill.
-
R-Zero Raises $105 Million Series C to Improve the Indoor Air We Breathe
R-Zero’s UV-C Technology Improves Indoor Air Quality for Millions of People; Reduces Reliance on HVAC Systems and Chemicals…
-
SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational
Facility will produce high-performance ceramic armor products for personnel, aircraft, and vehicles
-
SINTX Technologies Announces Closing of $12.0 Million Public Offering
SINTX Technologies Announces Closing of $12.0 Million Public Offering
-
BioUtah on Capitol Hill
The Utah State Legislature has hit its halfway point in the 2023 session. Since day one, BioUtah President…
-
US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System and its BIOFIRE® SPOTFIRE® Respiratory (R) Panel
US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System
-
Renalytix announces a c.$20.3 million private placement
Renalytix announces a c.$20.3 million private placement
-
Sumitomo Pharma Oncology Presented Preliminary Data From Phase 1/2 Clinical Study Evaluating Investigational Agent TP-3654 in Patients With Myelofibrosis at American Society of Hematology 2022 Annual Meeting & Exposition
Sumitomo Pharma Oncology presented new data from the ongoing Phase 1/2 study evaluating TP-3654.
-
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in Multiple Sclerosis by Sanofi
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company…
-
Quansys Biosciences launches new NHP line of Multiplex ELISA Assays
NHP-specific ELISAs now available from Quansys Biosciences
-
UTAH’S LIFE SCIENCES INDUSTRY TAKES TO THE HILL
Utah’s vibrant life sciences industry was on full display January 27 as part of the Governor’s Office of…
-
BIOMERICS COMPLETES CONNECTICUT EXPANSION
SALT LAKE CITY, Jan. 20, 2023 /PRNewswire/ — Biomerics, the leading vertically integrated medical device contract manufacturer in…
-
Intermountain Healthcare is now “Intermountain Health”
Intermountain Healthcare has now officially changed its name to Intermountain Health, reflecting an added emphasis on keeping people…
-
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease
-
POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE
POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE
-
Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States
Award for consortium of industry, academic and clinical research leaders to develop personalized drug response tests in chronic…
-
Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as Chief Medical Officer
Halia Therapeutics announced the appointment of Dr. Margit M. Janát-Amsbury, MD, Ph.D. as the company’s Chief Medical Officer
-
Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Funding
ARUP Laboratories and the University of Utah’s Division of Medical Laboratory Sciences have secured $3 million in federal…
-
Inherent Biosciences Partners With Posterity Health to Accelerate the Path to Parenthood by Elevating the Standard of Care in Male Reproductive Health
Inherent Biosciences has teamed up with Posterity Health, the only virtual Male Fertility Center of Excellence, to address…
-
Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems
Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
